RBM45 and lung cancer: Moreover, we found that activation of the circ0515/RBM45/SDHB axis increases cisplatin resistance in lung cancer cells, potentially by enhancing oxidative phosphorylation, reducing cisplatin-induced ROS damage, and inhibiting apoptosis.